RENXReal Estate News Exchange (webiste;
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The joint venture, named RENX AI Labs, LLC, significantly expands the operational capacity available to RenalytixAI.
RENX AI Labs will help support the programs of pharmaceutical companies by applying AI-enabled diagnostics, beginning with KidneyIntelX, which is currently undergoing clinical validation, to improve patient characterisation and enrich targeting of patients for drug clinical trials for renal disease.
RENX AI Labs also has the capability to develop companion diagnostics under stringent quality-control processes.